UHV-21261-87259
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 961 / CA
- Registered
- 2021-06-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-25
Dose 1 — Pfizer-BioNTech
-
2021-06-26
Registered in v-safe
-
2021-06-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-06-27
- 2021-06-28
- 2021-06-30
- 2021-07-04
-
2021-07-09
Survey response — day 14, dose 1MedDRA: Hypersensitivity — Feeling: FairFree text: Environmental allergiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-16
Dose 2 — Pfizer-BioNTech
-
2021-07-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-07-18
- 2021-07-19
- 2021-07-22
- 2021-07-23
- 2021-08-01
- 2021-08-08
- 2021-08-13
- 2021-08-22
- 2021-08-27
- 2022-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-25 | Pfizer-BioNTech | No |
| 2 | 2021-07-16 | Pfizer-BioNTech | No |
Free text
Release 9 — day 14, dose 1
Symptoms: Environmental allergies
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release